Start a New Search
SHOWING 151 RESULTS
Regarding comments made by President Bush in his State of Union address on earmarking.
Research Administration & Regulation | Merit Review | StatementsRequest for collection of information on earmarks.
Research Administration & Regulation | Merit Review | MemoAAU issued a statement in 2005 concerning Congressional earmarking of federal research funds. It noted that earmarks may reduce the capacity of federal research agencies that sponsor merit-based competitions to support the most promising research.
Research Administration & Regulation | Merit Review | StatementsAAU urges Congress to provide $32 billion for the National Institutes of Health.
Federal Budget | Agency Budgets | National Institutes of Health | FY16 | Fact SheetsAAU sent Trump's transition team a comprehensive set of policy recommendations aimed at helping the nation sustain its preeminence in research, innovation, and higher education.
Research Administration & Regulation | Federal Budget | NASA | National Science Foundation | National Institutes of Health | Department of Defense | Department of Education | Department of Energy | Reducing Regulatory Burden | RecommendationBipartisan group of 145 MCs urges increased NIH funding.
Federal Budget | Agency Budgets | National Institutes of Health | FY16 | LettersAAU and APLU submitted brief comments today to the National Institutes of Health regarding updates to the NIH Grants Policy Statement, Section 15.2, on proposed requirements for consortium/subaward agreements on NIH-funded grants (notice:
Science & Security | National Institutes of Health | CommentsAAU submitted comments to the Department of Health and Human Services’ Office of Research Integrity regarding its notice of proposed rule making on Public Health Service Policies on Research Misconduct. AAU expressed concerns that the proposed regulations would “substantially increase – not…
National Institutes of Health | Research Administration & Regulation | MemoAAU, COGR comments to Dr. Franca R. Jones, Assistant Director—Chemical and Biological Countermeasures, Office of Science and Technology Policy, on the draft document "United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC)."
Science & Security | Biological & Chemical Security | Reducing Regulatory Burden | National Institutes of Health | LettersResponse to Request for Information (RFI): Input into the Deliberations of the Advisory Committee to the NIH Director Working Group on the Future Biomedical Research Workforce
Notice Number: NOT-OD-11-106
October 7, 2011
Innovation and Competitiveness | National Institutes of Health | Letters